Amgen And Sanofi Compete To Launch New Class Of Cholesterol-Fighting Drugs

Bidness ETC

Amgen has filed a Biologics License Application with the FDA for a new class of cholesterol-fighting drugs. It is competing with Sanofi to be the first to tap into the $10 billion market.
http://www.bidnessetc.com/24842-amgen-and-sanofi-compete-to-launch-new-class-of-cholesterolfighting-drugs/

http://www.americanflags4less.com: AMERICAN FLAGS 4 LESS

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s